Persistent inflammation, immunosuppression, and catabolism and the development of chronic critical illness after surgery.

[1]  R. Fowler,et al.  Increased Rate of Long-term Mortality Among Burn Survivors: A Population-based Matched Cohort Study. , 2019, Annals of surgery.

[2]  Derek C. Angus,et al.  Enhancing Recovery From Sepsis: A Review , 2018, JAMA.

[3]  R. Hotchkiss,et al.  Immunotherapy: It is not just for cancer anymore , 2018, Journal of leukocyte biology.

[4]  B. Brumback,et al.  Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients , 2017, The journal of trauma and acute care surgery.

[5]  B. Brumback,et al.  The Epidemiology of Chronic Critical Illness After Severe Traumatic Injury at Two Level–One Trauma Centers* , 2017, Critical care medicine.

[6]  Z. Tong,et al.  The long‐term quality of life in patients with persistent inflammation‐immunosuppression and catabolism syndrome after severe acute pancreatitis: A retrospective cohort study , 2017, Journal of critical care.

[7]  L. Sidossis,et al.  Propranolol and Oxandrolone Therapy Accelerated Muscle Recovery in Burned Children , 2017, Medicine and science in sports and exercise.

[8]  R. Fowler,et al.  Association Between Burn Injury and Mental Illness among Burn Survivors: A Population-Based, Self-Matched, Longitudinal Cohort Study. , 2017, Journal of the American College of Surgeons.

[9]  B. Brumback,et al.  Evidence for Persistent Immune Suppression in Patients Who Develop Chronic Critical Illness After Sepsis , 2017, Shock.

[10]  K. Tarte,et al.  Early Expansion of Circulating Granulocytic Myeloid‐derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis , 2017, American journal of respiratory and critical care medicine.

[11]  B. Brumback,et al.  Sepsis and Critical Illness Research Center investigators: protocols and standard operating procedures for a prospective cohort study of sepsis in critically ill surgical patients , 2017, BMJ Open.

[12]  M. Netea,et al.  The immunopathology of sepsis and potential therapeutic targets , 2017, Nature Reviews Immunology.

[13]  B. Brumback,et al.  Human Myeloid-derived Suppressor Cells are Associated With Chronic Immune Suppression After Severe Sepsis/Septic Shock , 2017, Annals of surgery.

[14]  L. Moldawer,et al.  Persistent Inflammation, Immunosuppression and Catabolism Syndrome. , 2017, Critical care clinics.

[15]  L. Moldawer,et al.  Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome , 2017, Critical care medicine.

[16]  S. Brakenridge,et al.  The long-term burden of severe sepsis and septic shock: Sepsis recidivism and organ dysfunction , 2016, The journal of trauma and acute care surgery.

[17]  S. Opal,et al.  Long-Term Quality of Life Among Survivors of Severe Sepsis: Analyses of Two International Trials* , 2016, Critical care medicine.

[18]  C. Andersen,et al.  Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children , 2016, Annals of surgery.

[19]  R. Hotchkiss,et al.  Sepsis and septic shock , 2016, Nature Reviews Disease Primers.

[20]  A. Cardoso,et al.  Sepsis Induces Hematopoietic Stem Cell Exhaustion and Myelosuppression through Distinct Contributions of TRIF and MYD88 , 2016, Stem cell reports.

[21]  F. Moore,et al.  Persistent Inflammation, Immunosuppression, and Catabolism: Evolution of Multiple Organ Dysfunction. , 2016, Surgical infections.

[22]  A. Ravaud,et al.  Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. , 2015, The New England journal of medicine.

[23]  M. Valsecchi.  Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. , 2015, The New England journal of medicine.

[24]  H. Baker,et al.  A Detailed Characterization of the Dysfunctional Immunity and Abnormal Myelopoiesis Induced by Severe Shock and Trauma in the Aged , 2015, The Journal of Immunology.

[25]  G. Hoser,et al.  Early severe impairment of hematopoietic stem and progenitor cells from the bone marrow caused by CLP sepsis and endotoxemia in a humanized mice model , 2015, Stem Cell Research & Therapy.

[26]  L. Crinò,et al.  Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. , 2015, The New England journal of medicine.

[27]  Dirk Schadendorf,et al.  Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. , 2015, The New England journal of medicine.

[28]  F. Moore,et al.  Persistent inflammatory, immunosuppressed, catabolic syndrome (PICS): A new phenotype of multiple organ failure. , 2015, Journal of advanced nutritional and human metabolism.

[29]  R. Hotchkiss,et al.  Parallels between cancer and infectious disease. , 2014, New England Journal of Medicine.

[30]  A. Dzutsev,et al.  Host immune response to infection and cancer: unexpected commonalities. , 2014, Cell host & microbe.

[31]  H. Baker,et al.  Aged Mice Are Unable To Mount an Effective Myeloid Response to Sepsis , 2014, The Journal of Immunology.

[32]  Z. Balogh,et al.  Changes in the epidemiology and prediction of multiple-organ failure after injury , 2013, The journal of trauma and acute care surgery.

[33]  R. Barrow,et al.  Long-Term Propranolol Use in Severely Burned Pediatric Patients: A Randomized Controlled Study , 2012, Annals of surgery.

[34]  M. Heikenwalder,et al.  Cutting Edge: LPS-Induced Emergency Myelopoiesis Depends on TLR4-Expressing Nonhematopoietic Cells , 2012, The Journal of Immunology.

[35]  L. Moldawer,et al.  Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care , 2012, The journal of trauma and acute care surgery.

[36]  D. Schoenfeld,et al.  Benchmarking Outcomes in the Critically Injured Trauma Patient and the Effect of Implementing Standard Operating Procedures , 2012, Annals of surgery.

[37]  R. Tompkins,et al.  The changing pattern and implications of multiple organ failure after blunt injury with hemorrhagic shock* , 2012, Critical care medicine.

[38]  John D. Storey,et al.  A genomic storm in critically injured humans , 2011, The Journal of experimental medicine.

[39]  E. Pietras,et al.  Cell cycle regulation in hematopoietic stem cells , 2011, The Journal of cell biology.

[40]  D. Herndon,et al.  Long-Term Persistance of the Pathophysiologic Response to Severe Burn Injury , 2011, PloS one.

[41]  T. Koepsell,et al.  Long-term survival of adult trauma patients. , 2011, JAMA.

[42]  Lyle L. Moldawer,et al.  A Paradoxical Role for Myeloid-Derived Suppressor Cells in Sepsis and Trauma , 2011, Molecular medicine.

[43]  M. Goodell,et al.  Inflammatory signals regulate hematopoietic stem cells. , 2011, Trends in immunology.

[44]  Arthur S Slutsky,et al.  Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome. , 2006, American journal of respiratory and critical care medicine.

[45]  R. Hotchkiss,et al.  Characterization of the Systemic Loss of Dendritic Cells in Murine Lymph Nodes During Polymicrobial Sepsis12 , 2004, The Journal of Immunology.

[46]  C. Cocanour,et al.  Abdominal compartment syndrome: the cause or effect of postinjury multiple organ failure. , 2003, Shock.

[47]  Arthur S Slutsky,et al.  One-year outcomes in survivors of the acute respiratory distress syndrome. , 2003, The New England journal of medicine.

[48]  Y. Furukawa,et al.  Cell cycle regulation of hematopoietic stem cells. , 1998, Human cell.

[49]  R. Bone,et al.  Immunologic Dissonance: A Continuing Evolution in Our Understanding of the Systemic Inflammatory Response Syndrome (SIRS) and the Multiple Organ Dysfunction Syndrome (MODS) , 1996, Annals of Internal Medicine.

[50]  A. Sauaia,et al.  Postinjury multiple organ failure: a bimodal phenomenon. , 1996, The Journal of trauma.

[51]  E. Moore,et al.  Evolving concepts in the pathogenesis of postinjury multiple organ failure. , 1995, The Surgical clinics of North America.

[52]  E. Faist,et al.  Multiple organ failure in polytrauma patients. , 1983, The Journal of trauma.

[53]  S. Brakenridge,et al.  Chronic Critical Illness: Application of What We Know. , 2018, Nutrition in clinical practice.

[54]  A. Sauaia,et al.  STILL RESOURCE-INTENSIVE , MORBID AND LETHAL , 2013 .

[55]  Julie R. Boiko,et al.  Hematopoiesis sculpted by pathogens: Toll-like receptors and inflammatory mediators directly activate stem cells. , 2012, Cytokine.

[56]  A. Ellrodt,et al.  Sepsis and septic shock. , 1986, Emergency medicine clinics of North America.